Comparison of Ormeloxifene versus Tranexamic acid in the management of abnormal uterine bleeding in reproductive age group women - a randomized control trial
Not Applicable
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 3: N948- Other specified conditions associated with female genital organs and menstrual cycle
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women aged 25-44 years with complaints of menorrhagia and willing to participate in the study
Exclusion Criteria
1.Pregnancy
2,Women who have delivered within the last 1 year
3.Women who have had abortions in the past 3 months
4.Any drug allergy
5.Post menopausal women
6.Fibroid
7.Adenomyosis
8.Endometriosis
9.Cervical dysplasia
10.Endometrial hyperplasia with atypia
11.Thyroid disorders
12.Breast and genital malignancies
13.Hepatic and renal dysfunction
14.Patient already on antifibrinolytic therapy
15.Patient already on any hormonal therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method